A newly identified nontranscriptional mechanism of the transcription factor AP-2α, known as TFAP2A, enables gallbladder cancer cells to withstand severe bile acid stress by stabilizing the Golgi protein GOLIM4. According to experimental findings across patient tissues, organoid cultures, and animal models, bile acid challenge induces TFAP2A to accumulate in the cytoplasm, where it binds directly to GOLIM4 and shields it from ubiquitin-mediated degradation. This molecular interaction preserves Golgi architecture, alleviates endoplasmic reticulum stress, and promotes the survival and proliferation of gallbladder cancer cells within a hostile microenvironment.

Gallbladder cancer is pathologically characterized by a microenvironment rich in bile acids, which exerts profound endoplasmic reticulum stress on resident cells. Although TFAP2A was previously recognized as being upregulated in gallbladder cancer tissues, its specific functional contribution within this bile acid-rich stress context remained undefined. The study investigated the mechanisms through which malignant cells utilize elevated TFAP2A expression to achieve physiological adaptation and sustained survival when exposed to bile acid pressure.

To assess TFAP2A expression patterns and clinical relevance, the investigators analyzed gallbladder cancer tissue samples obtained from human patients using RNA sequencing, immunohistochemical staining, and western blot assays. These analyses confirmed that TFAP2A is highly expressed in tumor specimens. Furthermore, the clinical evaluations revealed that TFAP2A exhibits marked cytoplasmic accumulation, with the degree of cytoplasmic localization correlating directly with measured bile acid levels in the tissue microenvironment.

To elucidate the cytoplasmic activity of this transcription factor, the researchers mapped its protein binding partners using astral data-independent acquisition proteomics, with specific candidate interactions subsequently verified through coimmunoprecipitation. These biochemical screenings demonstrated a direct physical interaction between cytoplasmic TFAP2A and the Golgi-associated protein GOLIM4. Further evaluation using cycloheximide chase experiments and ubiquitination assays established that TFAP2A stabilizes GOLIM4 by actively inhibiting its ubiquitin-mediated degradation.

The stabilization of GOLIM4 by TFAP2A proved essential for cellular organelle maintenance and stress mitigation, as tracked through immunofluorescence microscopy and western blot profiling of cellular stress markers. The functional TFAP2A/GOLIM4 complex preserved structural Golgi integrity during bile acid stress while mitigating endoplasmic reticulum stress pathways. This protective response was biochemically confirmed by a marked downregulation of the proapoptotic factor CHOP alongside an upregulation of the endoplasmic reticulum chaperone GRP78, also known as BiP.

The functional consequences of this protective axis were tested in vitro using cellular models and patient-derived organoids subjected to bile acid stress. These assays demonstrated that TFAP2A and GOLIM4 activity promoted cancer cell survival, sustained cell proliferation, and enhanced overall tumor growth capacity. In contrast, experimental knockdown of either TFAP2A or GOLIM4 abrogated these malignant properties and significantly sensitized the cancer cells to stress conditions.

The physiological requirement for the TFAP2A/GOLIM4 pathway was further verified in vivo using both cell-derived xenograft and patient-derived xenograft animal models. Targeted depletion of either TFAP2A or GOLIM4 significantly suppressed tumor growth in the xenograft models. Consistent with the in vitro cellular observations, the suppression of tumor growth following TFAP2A or GOLIM4 knockdown was accompanied by an increase in endoplasmic reticulum stress-induced apoptotic cell death in vivo.

Together, the experimental findings describe an adaptive, nontranscriptional role for TFAP2A during bile acid stress in gallbladder cancer. By preventing GOLIM4 degradation and bolstering cellular secretory capacity, the TFAP2A/GOLIM4 axis functions as an adaptive pathway that operates independently of classical unfolded protein response mechanisms to confer a survival advantage. The authors conclude that disrupting this specific protein-protein interaction may provide a targeted therapeutic strategy for managing aggressive gallbladder malignancies.

The identification of this UPR-independent pathway highlights a distinct survival adaptation tailored to the extreme conditions of the gallbladder. While gallbladder cancer cells must continuously manage the severe endoplasmic reticulum stress imposed by high bile acid concentrations, the translocation of TFAP2A to the cytoplasm provides an alternate, non-genomic route to maintain cellular equilibrium. By directly preserving the Golgi apparatus through GOLIM4 stabilization rather than relying solely on transcriptional reprogramming, the cells sustain their secretory capacity to endure microenvironmental pressure.

These protective mechanisms reflect preclinical findings rather than direct clinical outcomes in human patients. The survival advantages conferred by the TFAP2A/GOLIM4 axis, as well as the suppression of malignant phenotypes and increased apoptosis following gene knockdown, were documented strictly in laboratory cell cultures, patient-derived organoids, and xenograft models. While the authors suggest that disrupting this protein interaction could offer a new therapeutic strategy for gallbladder cancer, the approach remains untested in human clinical trials, where the efficacy and safety of targeting this nontranscriptional pathway have yet to be established.

Subject of Research: Nontranscriptional function of TFAP2A in gallbladder cancer survival under bile acid stress

Article Title: Bile acid stress induces a nontranscriptional function of TFAP2A via stabilizing GOLIM4 to promote gallbladder cancer survival

Article References: Tang, N., Gu, A., Zuo, J., Li, M., Wang, Z., Jia, Z., Qiu, S., Li, X., Feng, J., Xue, T., Zhai, S., Yue, Z., An, Y., Kang, S., Yuan, Z., Xue, Y., Liu, L., Li, J., & Liu, Y. (2026). Bile acid stress induces a nontranscriptional function of TFAP2A via stabilizing GOLIM4 to promote gallbladder cancer survival. Cellular & Molecular Biology Letters. https://doi.org/10.1186/s11658-026-00989-7

Image Credits: AI Generated

DOI: 10.1186/s11658-026-00989-7

Keywords: TFAP2A, GOLIM4, gallbladder cancer, bile acid stress, endoplasmic reticulum stress, Golgi integrity, CHOP, GRP78, BiP, patient-derived organoids, patient-derived xenografts, ubiquitination assays, cycloheximide chase, coimmunoprecipitation, DIA proteomics, tumor growth, cell proliferation, unfolded protein response